FCG
ELV icon

Fielder Capital Group’s Elevance Health ELV Stock Holding History

Fielder Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
1,190
+87
+8% +$32.3K 0.1% 152
2026
Q1 		$323K Sell
1,103
-113
-9% -$37.1K 0.07% 182
2025
Q4 		$426K Buy
1,216
+30
+3% +$10.1K 0.09% 133
2025
Q3 		$383K Sell
1,186
-112
-9% -$34.8K 0.09% 138
2025
Q2 		$505K Sell
1,298
-202
-13% -$81.2K 0.13% 103
2025
Q1 		$653K Buy
1,500
+186
+14% +$74.7K 0.19% 75
2024
Q4 		$485K Sell
1,314
-148
-10% -$61.9K 0.15% 100
2024
Q3 		$760K Buy
1,462
+58
+4% +$31K 0.25% 67
2024
Q2 		$761K Sell
1,404
-6
-0.4% -$3.17K 0.29% 60
2024
Q1 		$731K Buy
1,410
+9
+0.6% +$4.48K 0.33% 53
2023
Q4 		$661K Buy
+1,401
New +$648K 0.4% 54

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fielder Capital Group's ELV Position: Q2 2026 in Review

Fielder Capital Group increased its Elevance Health (ELV) stake by 7.9% in Q2 2026, buying an estimated $32.3K and bringing the position to 1,190 shares worth $460K. The position accounts for 0.1% of the portfolio, ranked #152.

Fielder Capital Group first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $761K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fielder Capital Group held 1,190 shares of Elevance Health worth $460K as of Q2 2026.
  • Fielder Capital Group bought 87 Elevance Health shares in Q2 2026, an estimated $32.3K.
  • Elevance Health made up 0.1% of Fielder Capital Group's portfolio in Q2 2026, its #152 holding.
  • Fielder Capital Group first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Fielder Capital Group's Elevance Health position peaked at $761K in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.